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Background: Early diagnosis of dengue virus infection during the febrile stage is essential for adjusting appropriate
management. This study is to identify the predictive markers of clinical and laboratory findings in the acute stage of
dengue infection during a major outbreak of dengue virus type 1 that occurred in southern Taiwan during 2007. A
retrospective, hospital-based study was conducted at a university hospital in southern Taiwan from January to December,
2007. Patient who was reported for clinically suspected dengue infection was enrolled. Laboratory-positive dengue cases
are confirmed by enzyme-linked immunosorbent assay of specific dengue IgM, fourfold increase of dengue-specific IgG
titers in convalescent serum, or by reverse transcription-polymerase chain reaction (RT-PCR) of dengue virus.
Results: The suspected dengue cases consist of 100 children (≤ 18 years) and 481 adults. Among the 581 patients,
67 (67%) children and 309 (64.2%) adults were laboratory-confirmed. Patients who had laboratory indeterminate were
excluded. Most cases were uncomplicated and 3.8% of children and 2.9% of adults developed dengue hemorrhagic
fever or dengue shock syndrome (DHF/DSS). The overall mortality rate in those with DHF/DSS was 7.1%, and the
average duration of hospitalization was 20 days. The most common symptoms/signs at admission were myalgia
(46.8%), petechiae (36.9%) and nausea/vomiting (33.5%). The most notable laboratory findings included leukopenia
(2966 ± 1896/cmm), thrombocytopenia (102 ± 45 × 103/cmm), prolonged activated partial thromboplastin time (aPTT)
(45 ± 10 s), and elevated serum levels of aminotransferase (AST, 166 ± 208 U/L; ALT, 82 ± 103 U/L) and low C - reactive
protein (CRP) (6 ± 11 mg/L). Based on the clinical features for predicting laboratory-confirmed dengue infection, the
sensitivities of typical rash, myalgia, and positive tourniquet test are 59.2%, 46.8%, and 34.2%, while the specificities for
above features are 75.4%, 53.5% and 100%, respectively. The positive predictive value (PPV) for combination of
leukopenia, thrombocytopenia (< 150 × 103/cmm), elevated aminotransferase (AST/ALT > 1.5) and low CRP (< 20 mg/L)
is 89.5%, while the negative predictive value is 37.4%. Furthermore, the PPV of the combination was increased to 93.1%
by adding prolonged aPTT (>38 secs).
Conclusions: Leukopenia, thrombocytopenia, elevated aminotransferases, low CRP and prolonged aPTT, were useful
predictive markers for early diagnosis of dengue infection during a large outbreak in southern Taiwan.
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Dengue disease is an acute infectious disease caused by
four serotypes of dengue virus, and is the most prevalent
mosquito-borne viral disease in humans, occurring in
tropical and subtropical countries of the world where
over 2.5 billion people are at risk of infection [1]. The* Correspondence: liucc@mail.ncku.edu.tw
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reproduction in any medium, provided the orWorld Health Organization has estimated 50 million
cases of dengue fever and several hundred thousand
cases of dengue hemorrhagic fever occur each year, de-
pending on the epidemic activity [2]. Some 1.8 billion of
the population at risk for dengue worldwide live in
member states of the WHO South-East Asia Region and
Western Pacific Region, which bear nearly 75% of the
current global disease burden due to dengue [3].
Dengue has a wide spectrum of clinical presentations,
often with unpredictable clinical evolution and outcome.
While most patients recover following a self-limiting non-
severe clinical course, a small proportion progress to severeThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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without hemorrhage. Early recognition of dengue is chal-
lenging because the initial symptoms are often non-specific,
viremia may be below detectable levels and serological tests
confirm dengue late in the course of illness [4]. Prompt
diagnosis during the febrile stage is essential for adjusting
appropriate management [5].
In endemic areas such as Southeast Asia or Latin America,
dengue hemorrhagic fever is the leading cause of hospi-
talization and death among children with secondary infec-
tion. In different areas with a recent introduction of the
virus or with no endemicity, the age distribution of dengue
hemorrhagic fever cases is different with an increasing
number of adults with DHF [6]. In 1987, a major dengue
outbreak occurred in southern Taiwan [7]. Several major
dengue endemics with various clinical characteristics and
serotypes were observed in Taiwan during the past two
decades [8,9].
Dengue is a category 2 notified infectious disease in
Taiwan; the physicians are obliged to report the sus-
pected dengue cases to the local health department
within 24 hours of clinical diagnosis. Contacts of con-
firmed cases are also obliged to test their blood for den-
gue virus infection. Reliably identifying dengue patients
early in their clinical course could help direct patient
management and reduce the transmission of dengue virus
in a community. Timely identification of dengue infection
would enable healthcare providers potentially to prevent
additional cases among close contacts by urging patients
with a positive dengue screening test to use personal
protection measures against mosquito bites [4]. How-
ever, there are no accepted clinical guidelines for the
recognition of early-stage dengue infection. There is
also no consensus as to whether clinical features can be
used to distinguish dengue infection from other febrile
illness [10-14].Figure 1 Category algorithm for 581 clinically suspected dengue caseThis study is aimed to identify the predictive markers
of clinical and laboratory findings in the early stage of
dengue infection during the outbreak in Southern Taiwan
in 2007.Methods
Case definition
A retrospective, hospital-based study was conducted at
National Cheng Kung University Hospital from Jan. to
Dec., 2007. Patient who was reported for clinically
suspected dengue infection was enrolled. Laboratory-
positive dengue cases are confirmed by enzyme-linked
immunosorbent assay of specific dengue IgM, fourfold
increase of dengue-specific IgG titers in convalescent
serum, or by reverse transcription-polymerase chain re-
action (RT-PCR) of dengue virus. Pediatric patients are
defined as patients who younger than 18 years.
Suspected dengue cases were defined as: patients with
reported or documented fever of ≥38°C of less than 7 days
duration and two or more symptoms or signs (headache,
rash, eye pain, myalgia, arthralgia, hypotension, hemorrhage,
hemoconcentration (elevated hematocrit ≥20% for age
and gender, or equivalent drop in hematocrit (≥20% from
baseline) after volume replacement therapy), thrombo-
cytopenia (platelet count <150 × 103/cmm) or for whom a
physician suspected dengue for any reason. All clinically
suspected dengue cases were categorized into three fol-
lowing groups (Figure 1): (a) laboratory-positive dengue
case: suspected dengue case with anti-dengue IgM sero-
conversion or single anti-dengue IgM positivity or with
dengue virus identification through RT-PCR. (b) laboratory-
negative dengue case: suspected dengue negative for anti-
dengue IgM antibodies in convalescent specimen; nei-
ther dengue virus nor anti-dengue IgM detected in the
acute specimen. (c) laboratory-indeterminate dengue case:s during the 2007 outbreak in southern Taiwan.
Table 1 Demographic characteristics and diagnosis of 376
dengue patients during the 2007 outbreak in southern
Taiwan
≥ 18 y/o <18 y/o P*
Total (n,%) 309 (82.1%) 67(17.9%)
Gender
Male 145 (46.9%) 45 (64.3%) 0.088
Female 164 (53.1%) 22 (35.7%)
Age (years)** 48 (19–83) 14 (2–18)
Hospitalization (%) 79% 78% 0.655
Hospital stay (days) 4.1 ± 3.1 3.4 ± 2.6 0.204
Diagnosis
Dengue Fever 297 (96.2%) 65 (97.1%)
DHF/DSS 12 (3.8%) 2 (2.9%)
DHF/DSS: dengue hemorrhagic fever/dengue shock syndrome.
*Chi-square test or t-test, **median (range).
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neither dengue virus nor anti-dengue IgM detected in the
acute specimen. Data from medical records were also col-
lected, including demographic information, data on the
timing of hospital visits, comorbidities, clinical features,
and laboratory data. Clinical symptoms/signs such as
myalgia, petechiae, skin rashes, headache, itching skin,
nausea/vomiting, diarrhea were recorded. Positive tour-
niquet test [10] was defined if there are more than 20
petechiae in a defined 2.5-cm2 area. Cut-off values for
laboratory tests were defined as followings: leukopenia
(white blood cell count < 4000/cmm), thrombocytopenia
(platelet count < 150 × 103/cmm) prolonged activated
partial thromboplastin time (aPTT) (> 38 sec), elevated
serum aminotransferase levels (aspartate aminotransfer-
ase (AST) or alanine aminotransferase (ALT) >39 U/L)
and low C-reactive protein (CRP) (< 20 mg/L). The
chart review followed published guidelines on retro-
spective chart review methods to ensure accurate data
abstraction and to limit the biases inherent to such
studies [15]. The institutional review board of National
Cheng Kung University Hospital approved the study
protocol.
Sample collection and dengue diagnosis
The collection of serum samples and laboratory diagno-
sis are performed for public health surveillance purposes
and enforced by the Communicable Disease Prevention
Act. A modified E/M-specific captured IgM and IgG
ELISA was performed to measure the dengue virus
(DENV) and Japanese encephalitis virus (JEV)-specific
IgM and IgG antibodies as previously described [16-18].
The assay was performed by (1) measurement of DENV-
and JEV-specific IgM and IgG antibodies of each serum
sample simultaneously in the same ELISA plates, (2) se-
lection of a monoclonal antibody having similar affinity
to both JEV and the four DENV serotypes, (3) addition
of virus-infected cell culture supernatants containing
equal concentration of DENV or JEV in each well, and
(4) captured IgM or IgG antibodies incubated to a cock-
tail of mixed viral antigens and the monoclonal antibody
in a single step. A one-step SYBR Green I real-time RT-
PCR (QuantiTect SYBR Green RT-PCR kit; Qiagen,
Hilden, Germany) was performed in the Mx4000TM
quantitative PCR system (Stratagene, La Jolla, CA) to de-
tect and differentiate dengue virus serotypes in acute-
phase serum samples, as described previously [17,18].
Statistical analysis
Statistical analyses were performed using Fisher’s exact
test for categorical variables and the t test for continuous
variables. Clinical and laboratory findings were com-
pared using SPSS version 11.5 (SPSS, Chicago, IL, USA).
p values less than 0.05 were considered significant. Thesensitivity and specificity of the items for predicting den-
gue infection were determined for each assigned cut-off
value.
Results
Dengue virus type 1 (DENV-1) was most common sero-
type detected by RT-PCR in this study (93% in adults,
96% in children), whereas DENV-2 was also detected.
Most cases were uncomplicated and only 3.8% of chil-
dren and 2.9% of adults developed dengue hemorrhagic
fever or dengue shock syndrome (DHF/DSS). The over-
all yield rate for RT-PCR was 49.2% (185/376). The posi-
tive rate of RT-PCR at admission was similar between
adult and pediatric groups (51% vs. 40%, p = 0.317).
Most of the patient was hospitalized (79% in adults vs.
78% in children, p = 0.655) for an average of 3.4 ~ 4.1 days
(4.1 ± 3.1 days in adults vs. 3.4 ± 2.6 days in children, p =
0.204) (Table 1). The overall mortality rate in those with
DHF/DSS was 7.1%, and the mean duration of hospitali-
zation was 20 days.
The peak period of this outbreak was in October-
November (240, 63.8%) and there was no confirmed
dengue case after Dec 31, 2007 (Figure 2). The enrolled
suspected dengue cases during the study period consist
of 100 children (≤ 18 years) and 481 adults. Among the
581 patients, 67 (67%) children and 309 (64.2%) adults
were laboratory-positive. Patients who had laboratory in-
determinate were excluded. The median age was 13 years
in children and 48 years in adults. There were no gender
predominance either in adult or pediatric groups (46.9%
male in adult vs. 64.3% in children, p = 0.088).
The mean febrile duration in adults (5.1 ± 1.5 days)
and children (6 ± 1.7 days) were similar (p = 0.459). Most
of the patients visit our hospital within the 4th day of
disease. The most common clinical presentations in either
adult or pediatric dengue patients were myalgia (46.2% vs.
Figure 2 Monthly distributions of laboratory-confirmed dengue patients in southern Taiwan, 2007.
Table 2 Clinical presentations and laboratory features of
376 dengue patients in first visit to clinic during the
2007 outbreak in southern Taiwan
≥18 y/o <18 y/o P*
Febrile days 5.1 ± 1.5 6 ± 1.7 0.459
Fever to clinic (days) 4.1 ± 2.1 4 ± 1.7 0.522
Symptoms/signs
Myalgia 46.9% 46.2% 0.827
Petechiae 34.3% 49.2% 0.275
Headache 31.1% 38.8% 0.116
Itching skin 12.5% 49.2% <0.05
Nausea/vomiting 31.1% 44.7% 0.144
Diarrhea 23.4% 26.5% 0.707
WBC (/cmm) 3564 ± 1719 2971 ± 1761 0.006
PLT (×103/cmm) 96 ± 51 102 ± 46 0.459
AST (U/L) 126 ± 132 166 ± 206 0.272
ALT (U/L) 81 ± 77 80 ± 101 0.492
CRP (mg/L) 20 ± 24 6 ± 11 0.011
aPTT (sec) 39 ± 6 44 ± 10 0.021
*Chi-square test or t-test, Figures were presented as mean ± standard
deviation, WBC: white blood cell, PLT: platelet, AST: aspartate
aminotransferase, ALT: alanine aminotransferase, CRP: C-reactive protein, aPTT:
activated partial thrombin time.
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and nausea/vomiting (44.7% vs. 31.1%. p = 0.144). How-
ever, almost half of the pediatric patients had itching skin,
which is less frequent in adults (49.2% vs. 12.5%, p < 0.05).
Gastrointestinal symptoms including nausea/vomiting and
diarrhea were also leading complaints in this epidemic
(Table 2).
The most notable laboratory findings included leukope-
nia, thrombocytopenia, prolonged aPTT, elevated serum
levels of aminotransferase and low CRP. Lower WBC
(2971 ± 1761/cmm vs. 3564 ± 1719/cmm, p = 0.006) and
CRP level (6 ± 11 mg/L vs. 20 ± 24 mg/L, p = 0.011) and
longer aPTT (39 ± 6 secs vs. 44 ± 10 secs, p = 0.021)
were frequent to encounter in dengue-infected children
(Table 2).
In comparison with laboratory-confirmed dengue-
negative cases, dengue-positive patient had more head-
ache (32.4% vs. 14%, p < 0.01), nausea/vomiting (33.5%
vs. 15.8%, p < 0.01) and diarrhea (23.9% vs. 12.3%, p =
0.012). Dengue-positive cases also lower average WBC
count (3458 vs. 5950/cmm, p < 0.01), platelet count (97
vs. 147 × 103/cmm, p < 0.01), serum alanine aminotrans-
ferase (81 U/L vs. 134 U/L, p = 0.019) and CRP levels
(18 vs. 36, p < 0.01). Moreover, the average aaPTT was
longer in dengue-positive patients (40 secs vs. 31 secs,
p = 0.003) (Table 3).
To determine the predictive values of those common
clinical and laboratory characteristics for laboratory-
confirmed dengue infection, calculation were performed
based on the clinical/laboratory features for predicting
laboratory-confirmed dengue infection. The sensitivitiesof skin rash, myalgia, and positive tourniquet test are
59.2%, 46.8%, and 34.2%, while the specificities for above
features are 75.4%, 53.5% and 100%, respectively. Rash
and positive tourniquet test had high positive predictive
value (88.8% and 100%, respectively) (Table 4). However,
Table 3 Comparison of clinical and laboratory
characteristics between dengue positive and negative







Myalgia 46.8% 40.4% 0.274
Petechiae 36.9% 29.8% 0.201
Headache 32.4% 14.0% <0.01
Itching skin 8.6% 14.9% 0.075
Nausea/vomiting 33.5% 15.8% <0.01
Diarrhea 23.9% 12.3% 0.012
WBC (/cmm) 3458 ± 3956 5950 ± 2851 <0.01
PLT (K/cmm) 97 ± 122 147 ± 85 <0.01
AST (U/L) 133 ± 293 111 ± 241 0.466
ALT (U/L) 81 ± 150 134 ± 341 0.019
CRP (mg/L) 18 ± 29 36 ± 60 <0.01
aPTT (sec) 40 ± 45 31 ± 3 0.003
*Chi-square test or t-test, Figures were presented as mean ± standard
deviation, WBC: white blood cell, PLT: platelet, AST: aspartate
aminotransferase, ALT: alanine aminotransferase, CRP: C-reactive protein, APTT:
activated partial thrombin time.
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ical course of dengue infection, and was not a good pre-
dictor of acute dengue infection. Besides, Tourniquet
test was not routinely performed in clinical practice and
the sensitivity was also too low for acute dengue infection.
Therefore we measured several laboratory parameters as
predictors of laboratory-confirmed dengue infections. No
single laboratory test was good as enough in terms of
positive predictive value. However, we found that the posi-
tive predictive value (PPV) for combination of leukopenia,
thrombocytopenia, elevated aminotransferase and low
CRP is 89.5% and negative predictive value (NPV) is
37.4%. Furthermore, the PPV of the combination was
increased to 93.1% by adding prolonged aPTT. This
combination served a good predictive marker for acute
dengue infections (Table 5).Table 4 Value of selected clinical features in predicting a labo
patients during the 2007 outbreak in southern Taiwan
Laboratory feature Dengue (+) Dengue (−) Sensitivity
(1) Fever 253/376 99/114 67.3
(2) Rash 222/376 28/114 59.2
(3) Petechiae 184/376 85/114 37
(4) Myalgia 268/376 53/114 46.8
(5) Nausea/vomiting 126/376 38/114 33.5
(6) Positive tourniquet test* 178/263 0/68 34.2
*Numbers were presented as positive cases/examined cases.Discussion
For a dengue non-endemic area like Taiwan, early case
identification is the key for effective dengue control.
However, the revised 2009 symptom-based clinical man-
agement guideline from the World Health Organization
did not require laboratory-confirmation. The revised
classification of dengue cases is considered by many to
be too broad [19,20]. Accurate diagnosis of dengue in-
fection is of great important in non-endemic areas like
Taiwan, since the goal of dengue control is not only to
eliminate the occurrence of severe cases but also to con-
firm the possible dengue cases. However, the knowledge
and practice of healthcare professionals in Taiwan
seemed inadequate for the prompt case finding [21].
Universal laboratory for dengue infection are neither
economic nor efficient for most countries. Therefore,
there is a clinical need to determine who should take the
diagnostic test, virological or serological, in daily clinical
practice in Taiwan.
The early symptom/signs set of acute dengue virus in-
fection is variable and it is difficult to distinguish it from
other kinds of febrile illnesses [22,23]. Our study found
that a combination of commonly routine blood tests in-
cluding white blood count, platelet count, liver function
tests, and CRP and coagulation profiles is useful in
detecting laboratory-confirmed dengue infection. Previ-
ous study in Thailand showed that children with dengue
were more likely to report anorexia, nausea, and
vomiting and to have a positive tourniquet test. Dengue
infected children had also lower total white blood cell
counts, absolute neutrophil and absolute monocyte
counts, and higher plasma AST and ALT levels [10]. A
recent report also showed that patients with bleeding,
decrease in total protein, increase in blood urea and de-
crease in lymphocyte proportion had higher odds for de-
veloping dengue hemorrhagic fever [24]. Simple clinical
and laboratory markers can serve as an adjuvant in
addition to history and physical examination, and also
reduce the possible cost for universal laboratory diag-
nostic screening [14,24]. The symptoms combination
identified here while having high positive predictiveratory-positive diagnosis of dengue in suspected dengue










Table 5 Value of selected laboratory features in predicting a laboratory-positive diagnosis of dengue in suspected
dengue patients during the 2007 outbreak in southern Taiwan




(1) WBC <4000/cmm 315/376 53/114 83.8 53.5 85.6 50.0
(2) PLT < 150 × 103/cmm 314/376 52/114 83.5 54.4 85.8 50.0
(3) AST/ALT > 1.5 297/338 64/96 87.9 33.3 82.3 43.8
(4) CRP < 20 mg/L 335/357 75/102 93.8 26.5 81.7 55.1
(5) aPTT > 38 sec 227/301 37/80 75.4 53.8 86.0 36.8
(1) + (2) 276/376 52/114 73.4 45.6 84.1 34.2
(1) + (4) 291/357 34/102 81.5 66.7 89.5 50.7
(1) + (2) + (3) 228/338 38/96 67.5 60.4 85.7 34.5
(1) + (2) + (4) 255/357 27/102 71.4 73.5 90.4 42.4
(1) + (2) + (5) 209/301 26/80 69.4 67.5 88.9 37
(1) + (2) + (3) + (4) 221/338 26/96 65.4 72.9 89.5 37.4
(1) + (2) + (3) + (4) + (5) 172/301 11/80 49.5 86.3 93.1 31.2
WBC: white blood cell, PLT: platelet, AST: aspartate aminotransferase, ALT: alanine aminotransferase, CRP: C-reactive protein, aPTT: activated partial thrombin time.
*Numbers were presented as positive cases / examined case.
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addition to the clinical evaluation and there is still a need
to identify tests with better sensitivity and specificity. Be-
sides, the accuracy of dengue diagnostic tests depends on
the prevalence of dengue and time of sampling [25].
The difference in clinical manifestation between adult
and pediatric dengue infections have been an important
issue. A previous study in Taiwan showed that adult pa-
tients have higher incidences of arthralgia, myalgia, head-
ache, abdominal pain and upper gastrointestinal bleeding.
The adult dengue patient also had lower platelet counts,
prothrombin time and serum albumin levels. The inci-
dence of elevated alanine aminotransferase levels and
prevalence of dengue hemorrhagic fever in adults are
also higher than children [26]. The clinical manifesta-
tions in current study showed similarity between adult
and pediatric patients during the outbreak. Whereas,
the laboratory characteristics demonstrated significant
differences of WBC (p = 0.006), CRP (p = 0.011) and
aPTT (p = 0.021) between adult and pediatric dengue
patients.
Dengue poses a substantial economic and disease bur-
den in Southeast Asia [27]. The threshold for dengue ad-
mission in Taiwan is low, as showed in our study; nearly
80% of dengue patient were admitted to the hospital for
3–4 days. This finding is similar to Singapore [24], but
much higher than other countries in the Americas and
Asia. In a prospective health care facility-based study on
disease burden and cost of dengue illnesses in eight
endemic countries, around 45% were hospitalized for at
least one day [28]. High admission rate for suspected
dengue cases might compete the medical resources for
other diseases and increase the burden of healthcaresystems [20,27], simple predictive markers in this study
could provide a screening tool in a non-endemic area of
dengue. Dengue nonstructural protein 1 (NS1) antigen is
an early antigen presenting in sera of Dengue patients
and involves in the pathogenesis of dengue infection
[29]. NS1 antigen strip has also been suggested as a
rapid, easy-to-perform, sensitive, and specific test for the
early diagnosis of dengue infection after the onset of
fever [30]. Our predictive system could be either used to
decide the priority of NS1 antigen strip usage or to in-
crease the sensitivity/ specificity of the test.
The overall disease severity in this outbreak is rela-
tively lower than other studies. One of the possible ex-
planations is that most of our patients were infected by
dengue virus serotype 1. Dengue virus serotype 2 has
been associated with risk factors of developing dengue
hemorrhagic fever/dengue shock syndrome [29,31]. Be-
sides, high accessibility to medical services and low ad-
mission threshold provide early intervention and prevent
further morbidity/mortality. This practice is in line with
the 2009 WHO clinical management guideline, which
also encourage admitting patients with danger signs to
the medical facilities [20].
There are several limitations in our study. Firstly, the
retrospective and hospital-based design might not reflect
the whole dengue-infected groups. However, these re-
sults provide useful references for clinician practicing in
a non-endemic area of dengue. Secondly, the symptoms
combination identified while having high positive pre-
dictive value still had low sensitivity. Therefore, while it
may be a useful addition to the clinical evaluation, there
is still a need to identify tests with better sensitivity and
specificity. Finally, the study was conducted in a population
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the high positive predictive value will not be replicated in
a low prevalence population. The accuracy of these pre-
dictive markers might be subject to change in accordance
to the prevalence of dengue infection and alertness of
healthcare professionals. There is still no single clinical
and laboratory marker available for predicting dengue in-
fection, even the new WHO guideline [32].
Conclusions
Early diagnosis of dengue infection remains a challenge
to clinicians around the world. The positive predictive
value for laboratory-confirmed dengue infection with
combination of leukopenia (< 4000/cmm), thrombocytopenia
(< 150 × 103/cmm), prolonged aPTT (> 38 sec), elevated
aminotransferase (AST/ALT> 1.5) and low CRP (< 20 mg/L)
is 93.1%. These clinical and laboratory findings may serve
as predictive markers to promote early diagnosis of den-
gue infection in Taiwan.
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